Dr. Amir Hadanny, a certified neurosurgeon and hyperbaric and diving physician, is a leading researcher at the Sagol Center for hyperbaric medicine and research, Assaf-Harofeh medical center, Israel. Dr. Hadanny PhD thesis being done on the clinical applications of machine learning algorithms on medical data including the ability to predict HBOT outcome in post-concussion patients using the baseline brain imaging.
Dr. Hadanny research focus is on brain injuries, neuro-rehabilitation, and aging physiology. The work done by Dr. Hadanny combine applied research on humans’ side by side with animal models for further understating of physiological and pathophysiological processes.
For Abstract click here
Prof. Costantino Balestra started to study neurophysiology of fatigue then began studies on environmental physiology issues. He teaches physiology, biostatistics, research methodology, as well as other subjects. He Is the Director of the Integrative Physiology Laboratory and a full time professor at the Haute Ecole Bruxelles-Brabant (Brussels). He is VP of DAN Europe for research and education, Past President of the European Underwater and Baromedical Society, VP of the Belgian Society of Diving and Hyperbaric Medicine.
Dr. Shykoff is a senior research engineer at the Naval Aerospace Medical Research Laboratory (NAMRL), Naval Medical Research Unit – Dayton, Ohio, through the ORISE Established Scientist Program. Her specialty is applied respiratory physiology with interest in the interaction of the human and equipment, currently as applied to tactical aircraft. Before joining the team at NAMRL Dr. Shykoff was a research scientist at the Navy Experimental Diving Unit. There, she extensively studied pulmonary oxygen toxicity and effects of breathing resistance and carbon dioxide retention. Earlier in her career Dr. Shykoff investigated blood pressure control and cardiac output measurements from expired carbon dioxide at the University at Buffalo, and respiratory modulation of heart rate at the University of Toronto. Dr. Shykoff received her doctorate in Chemical Engineering through the Biomedical Engineering Unit at McGill University with research on the distribution of ventilation in the lungs. She belongs to a number of professional scientific organizations, is a guest reviewer for several journals, and is a member of the Aerospace Physiology Committee for the Navy Aviation Environment Scientific Advisory Board (AESAB) Respiratory Subcommittee.
For Abstract click here
Ben Aviner Ph.D. has specialized in hyperbaric neurophysiology, primarily in the context on HPNS etiology and mechanism.
For the past decade serves as a researcher in the Israel Naval Medical Institute, involved in animal and human studies dealing with CNS oxygen toxicity, nitrogen narcosis, decompression sickness and cold water exposure.
Trained and experienced as a Diving Instructor, Paramedic, Hyperbaric and Diving medicine, Aviation medicine, CCR and eCCR diver, sCCR and cave diver.
Dr. Bliznyuk is a research physiologist in the Hyperbaric Physiology Research Unit at the Israel Naval Medical Institute. She joined the staff in 2018 after completing her Ph.D. and a short post-doctoral fellowship at Ben-Gurion University of the Negev, under the supervision of Professor Yoram Grossman. In her postgraduate research work, she gained experience in a number of fields related to molecular neurobiology, brain physiology and diving medicine. These investigations required her to employ a variety of techniques and scientific approaches: Electrophysiology – two-electrode voltage clamp (TEVC) recording in the pressure chamber; Molecular Biology ‒ in vitro protein expression, immunoprecipitation, western blotting; Molecular Dynamics simulations; Bioinformatics ‒ protein evolutional development analysis.
She continues to collaborate with overseas partners, Professor Michael Hollman (Germany) and Dr. Yevgeny Moskovitz (Russia) on the subject of “Molecular mechanisms and neuroprotection in the High Pressure Neurological Syndrome (HPNS)”.
Her fields of interest also include broadening our understanding of the role of NMDA receptors in hyperbaric oxygen (HBO) toxicity.
Dr. Daniel P. Perl was born and raised in New York City and received his BA and MD degrees from Columbia College and the State University of New York. He then took postgraduate training in anatomic pathology and neuropathology at Yale University, following which he served for two years as a pathologist in the US Public Health Service, stationed at the Centers for Disease Control in Atlanta, Georgia. In subsequent years he served on the faculty of the Brown University Medical School and then the University of Vermont, College of Medicine. It was at Vermont that he began working on Alzheimer’s disease and other age-related neurodegenerative disorders. In 1986, Dr. Perl joined the Mount Sinai School of Medicine in New York, where for 24 years he served as Director of the Neuropathology Division and was Professor of Pathology, Psychiatry and Neurosciences. Dr. Perl has received numerous awards for his contributions to research and medical education.
Dr. Perl has authored over 290 peer-reviewed publications and book chapters and is co-author, with Professor Margaret Esiri, of the 3rd edition of Oppenheimer’s Diagnostic Neuropathology, a leading textbook in his field. He is highly regarded for his work on various aspects of the neuropathology of age-related neurodegenerative disorders, especially the role of environmental factors in their induction. He is a leading authority on the pathology of the fascinating complex of neurodegenerative disorders occurring among the native population living on Guam. In addition, he played a prominent role in the initial characterization of chronic traumatic encephalopathy (CTE) among former NFL football players.
In September, 2010, Dr. Perl left Mount Sinai to join the faculty of the Department of Defense’s Uniformed Services University of the Health Sciences, F. Edward Hébert School of Medicine, in Bethesda, MD. In conjunction with the congressionally mandated Center for Neuroscience and Regenerative Medicine, he has established a state-of-the-art neuropathology laboratory dedicated to research on the acute and long-term effects of traumatic brain injury (TBI) among military personnel. This culminated with his recent landmark publication in Lancet Neurology (15: 944-953, 2016) describing a distinctive and unique constellation of lesions in the brains of military personnel who had been exposed to blast TBI. This work continues and his groundbreaking findings have received considerable interest and attention from the lay media, the medical profession and the highest levels of the US Department of Defense and other Federal agencies.
For Abstract click here
Efrat Sasson holds a Ph.D., in Neuroscience from Tel-Aviv University, specializing on MRI correlates of cognitive function in aging and mild cognitive impairment.
Efrat brings vast experience in signal processing and MRI understanding and over the last years she performed analysis of research studies in collaboration with Sagol Center for HBOT, including evaluating MRI changes in the brain, hearts and kidneys following HBOT of in patients population. Over the last 8 years Efrat was a co-founder and the CEO of Wise-Imaging, a company that is specializing in advanced imaging.
For Abstract click here
Eldad Yaakobi is an exercise physiologist in Sagol Center for Hyperbaric Medicine and Research Assaf Harofeh Medical Center, Israel. Eldad brings over 10 years of experience in exercise physiology and specializes in cardiopulmonary exercise testing and cardiac rehabilitation.
Eldad received a B.Sc degree in pharmaceutical engineering from Jerusalem College of Engineering and a M.Sc degrees in Biomedical Sciences from The Hebrew University of Jerusalem.
For Abstract click here
Gil Suzin is the chief neuropsychologist at the Sagol Center for Hyperbaric Medicine and Research. He specializes in cognitive rehabilitation of patients with different neurological impairments and is involved in research and development of new cognitive assessment protocols. Gil’s PhD. research is centered on changes in visual encoding into memory of healthy elderly and MCI patients and it’s rehabilitation after a hyperbaric oxygen treatment intervention.
For Abstract click here
GILLIAN A. HOTZ, PH.D.
Research Professor, Department of Neurological Surgery
Director, KiDZ Neuroscience Center
Director, Concussion, WalkSafeTM, BikeSafeTM & SkateSafe TM Programs
I have been the Director of the KiDZ Neuroscience Center at the University Of Miami School Of Medicine since 2010. As a behavioral neuroscientist, my clinical interests have always been investigating the neurocognitive deficits of those individuals that have sustained a traumatic brain injury. I have co-authored two neurocognitive tests, The Brief Test of Head Injury for adults and the Pediatric Test of Brain Injury for children. My research also focuses on injury prevention; preventing brain and spinal cord injuries in children. In order to prevent these injuries, I have developed the WalkSafe program (2005), which has been shown to decrease the number of elementary school age children that get hit by cars, and the BikeSafe program (2009) to educate middle school age children on bicycle safety skills. As the Director of the UConcussion Program, we have a comprehensive countywide concussion care program including neurologic evaluation, neuroimaging, neuropharmacological management, and neuropsychological testing using ImPACT, a computerized neurocognitive screening measure with the Sports Medicine Institute and currently partnered with the Miami Dolphin Foundation. I am currently the site PI on a number of clinical trials;
TRACK-TBI: Transforming Research & Clinical Knowledge in Traumatic Brain Injury (TRACK-TBI), and an EEG device study to evaluate concussion on the sidelines also PI on Investigation Cannabinoids and Effects on Mild Traumatic Brain Injury
Ilan Kutz MD – A Trauma-Related Bio-Sketch
Ilan Kutz MD, emeritus professor of psychiatry at Tel-Aviv University, is a leading investigator in PTSD program at The Sagol center for hyperbaric medicine and research, Assaf Harofeh medical center, Israel. Dr. Kutz has many years of experience in diagnosing, treating and investigating Israeli PTSD soldiers & veterans and was the former Head of psychiatric services at Meir General Hospital, and the director of the stress and trauma intervention Unit.
For Abstract click here
Dr. Jacek Kot is a specialist in anesthesiology and intensive care and currently he is full time Associate Professor in Diving and Hyperbaric Medicine at Medical University of Gdansk, Poland serving also as the Chief of Research and Development of the National Centre for Hyperbaric Medicine in Gdynia, Poland. The Centre is equipped with several multiplace hyperbaric chambers, a dry saturation simulator with a ‘wet pot’, as well as the 6-bed Intensive Care Unit within the University Hospital. Since 2005, Jacek Kot has been Secretary General of the European Committee for Hyperbaric Medicine (ECHM), and from 2015 till 2018 he was the President of the European Underwater and Baromedical Society (EUBS). He has been involved in the international cooperation between European diving and hyperbaric centres (COST-B14, OXYNET, PHYPODE, DAN), as well as in the UHMS International Web-based Education Initiative. His professional interests include mainly HBOT in deep dives and saturation decompressions, as well as critically ill patients, especially with severe soft tissue infections.
Professor Jacob Ablin is specialist of general internal medicine and Rheumatology. He is head of Internal Medicine H at the Tel Aviv Sourasky medical center, Tel Aviv, Israel affiliated with the Sackler School of Medicine at the Tel Aviv University.
From 2002-2016, he served as the director of the fibromyalgia clinic at the Institute of rheumatology at the Tel Aviv Sourasky medical center.
Prof. Ablin was first author of the Israeli guidelines for the diagnosis and treatment of fibromyalgia, published in 2013. He was co-organizer of the first international symposium on fibromyalgia held at the Peres center for peace, Jaffa, Israel, on February 2013 and of the International Conference on controversies in Fibromyalgia held in Vienna, Austria, March 2019.
He is currently an elected member of the steering committee of the Israeli Society of rheumatology.
His main clinical and research interests are pathogenesis, genetics and epidemiology of the fibromyalgia syndrome.
He has scientific collaborations with several researchers worldwide, e.g. Professor Fred Wolfe, Wichita (USA), Professor Daniel Clauw, Michigan (USA), Professor Mary-Ann Fitzcharles, Montreal (Canada) Professor Winfried Häuser Munich (Germany) and Professor Dan Buskila Beer – Sheva (Israel).
For Abstract click here
Jean Claude Rostain, Ph.D., D.Sc. is an internationally recognized scientist
who has been working in Marseille on diving physiology for almost 40 years.
He has published over 150 scientific papers and 8 books in French and
English and remains one of the leading scientists in diving physiology in
France today. Dr. Rostain was President of the French Society Undersea and
Hyperbaric Medicine 1991-94 and Founder and Co-President of the
International High Pressure Biology Group 1988-95 and worked in JAMSTEC
Japan and the Clinical Research Centre in the United Kingdom as a visiting
scientists during the 1970’s and 1980’s.
His extensive research at basic and applied levels has often, in
collaboration with the French Navy and COMEX, involved neurophysiological
and psychometric performance studies during exposures to very high
pressures, responsible for the High Pressure Nervous Syndrome and Inert Gas
Narcosis. His work in recent years, using microdialysis methods, has shone
new light on the neurochemical changes induced by such pressures on the
brain, together with unique research on the effects of hydrogen and studies
with human divers to record depths of 701 m. In 1976 he was recipient of the
UHMS Oceaneering International Award, in 1995 the Arne Zetterstrom Medal,
in 1999 the Medal of the Undersea and Hyperbaric Medical and Physiological
French Society and in 2005 the Undersea and Hyperbaric Medical
Society premier award, the Albert R. Behnke Award.
Dr Joseph Caruana read for a B.Sc. (Hons.) in mathematics and physics at the University of Malta and for a doctorate in astrophysics at the University of Oxford. Following a postdoctoral position at the Leibniz Institute for Astrophysics Potsdam (AIP) in Germany, Dr Caruana joined the faculty of the Department of Physics and Institute of Space Sciences and Astronomy (ISSA) of the University of Malta, where he lectures on physics, astrophysics and philosophy of science.
Dr Caruana is a technical mixed-gas closed-circuit-rebreather diver and collaborating researcher with the hyperbaric unit at Malta’s general hospital, with an interest in data science and mathematical modelling for decompression
JP Imbert summarizes his diving career as an ability to be there at the right place at the right time. He started with Dr Lambertsen’s Predictive Study IV dive for a first encounter with isobaric counter diffusion. He continued at Comex as a research engineering, during the deep heliox and hydrogen programs that finally brought a man to 700 m in a chamber.
During the 80’s, he worked in Norway and in Brazil when the offshore industry developed deep interventions procedures to 300 msw.
When came the 90’s, he Comex Diving Manager, and written several generations of the Comex diving manuals. This period was also a drastic down turn in the offshore industry and he soon found himself stranded.
He then started technical diving in France with IANTD and became a trimix and rebreather instructor for 10 years.
Back in the offshore industry, he has since worked as a diving consultant. With the support of Technip, he has run several research programs on saturation decompression, HPNS monitoring and oxidative stress.
He admits enjoying equations and decompression modelling. Most of the current commercial diving tables are his design and he is still pursuing the quest of the ultimate decompression algorithm
Dr. Keren Doenyas-Barak obtained her Ph.D. from the Hebrew University in Jerusalem in 2002. She had practice Internal medicine and then Nephrology and is today a senior nephrologist at the nephrology department of Asaf Harofhe Medical Center.
Dr. Doenyas is a physician at the Sagol Center for Hyperbaric Medicine Asaf Harofe Medical Center, Israel where she studies the effect of HBOT on PTSD.
For Abstract click here
Prof. Dr. Andreas Koch, CptnN
is head of the Research Dept. of the Naval Institute of Maritime Medicine and head of Maritime Medicine Section, Institute of Experimental Medicine, Christian-Albrechts-University of Kiel, Germany.
Prof. Koch studied in Kiel, completed his Dissertation in the Institute of Pharmcology, fulfilled his board-certificaton for Internal Medicine and Sportsmedicine between 1996 and 2000 at the University Kiel, and obtained Professorship for both in 2014.
1996-1999 Numerous visits and close cooperation with the Naval Medical Research Center, Washington D.C., USA.
The main research topics are cellular and clinical effects of hyperbaric hyperoxia on human tissues, diving medicine and cardiovascular physiology, sports physiology, and motion sickness.
Currently, he is consultant and vice-president of the German Society of Diving and Hyperbaric Medicine (GTÜM e.V.).
Dr. Lyubisa (Luba) Matity is a consultant in Diving and Hyperbaric Medicine at Mater Dei Hospital’s Hyperbaric Unit in Malta. He holds postgraduate qualifications in Occupational Medicine and Underwater Medicine from Stellenbosch University, South Africa. Luba has extensive clinical experience in the field, including medical support to offshore commercial saturation diving. He is also a commercial diver himself (HSE accredited), a technical diver (TDI) and a diving instructor (PADI). During his diving medical career, which spans over two decades and three continents, he has treated more than 400 cases of acute Decompression Illness. He continues to have regular close clinical encounters with ‘oxygen intolerance’, so the subject of oxygen toxicity is of great interest to him.
Lynn M. Rothstein, Psy.D.
Dr. Rothstein is a Senior Clinical Pediatric Neuropsychologist who directs the Pediatric Neurocognitive Rehabilitation Division at the Sagol Center for Hyperbaric Medicine and Research at Assaf Harofe Medical Center. She is involved in research on the treatment effects of HBOT on post-concussed children. In addition, she runs a pediatric neurocognitive treatment center to address the needs of children who have suffered a TBI or neurodevelopmental insult to the brain. She has designed a unique treatment protocol consisting of cognitive remediation, virtual reality, biofeedback, psychotherapy and parent guidance. She is also actively involved in the research and design of new testing and treatment modalities.
Merav Catalogna, Ph.D
Dr. Merav Catalogna is a research scientist in Sagol Center for Hyperbaric Medicine and Research Assaf Harofeh Medical Center, Israel. She brings over 15 years of experience in multidisciplinary research and development projects from both the academia and the biomedical industry. Her areas of expertise include system engineering, medical signal processing, and machine learning applications, functional, and diffusion tensor MRI imaging, and bio-statistics.
Dr. Catalogna received a B.Sc degree in Physics, M.Sc and Ph.D degrees in Biomedical Engineering from Tel Aviv University.
For Abstract click here
Michael Hoffer, MD, FACS is a Professor of Otolaryngology and Neurological Surgery at the University of Miami. Dr. Hoffer assumed these roles after an over twenty year military career in which he studied mild Traumatic Brain Injury (mTBI) on active duty service members. Dr. Hoffer is a clinician-scientist who performs both basic and clinical research along with his Otology/Neurotology clinical practice. Dr. Hoffer’s lab focuses on traumatic damage to the inner ear and brain. He is authored over sixty papers and has a particular expertise in dizziness and balance disorders as well as neurosensory consequences after mild traumatic brain injury (mTBI). Dr. Hoffer and his collaborators have done pioneering work on pharmaceutical countermeasures for mTBI as well as optimized diagnosis and management of neurosensory disorders seen after mTBI. Dr. Hoffer graduated from UCSD Medical School, was a resident at the University of Pennsylvania, and did a Neurotology Fellowship at the Ear Research Foundation. He has an active clinical practice in otology/Neurotology and is very active in the University of Miami’s cochlear implant and hearing restoration services.
Nir Barzilai MD.
Director, Institute for Aging Research
at the Albert Einstein College of Medicine,
PI: Nathan Shock Center of Excellence in the Biology of Aging
PI: Glenn Center for the Biology of Human Aging.
Co-Scientific Director of the American Federation for Aging Research
Founder and on the Board of CohBar Inc.
Chief Medical Advisor for Life Bioscience
Dr. Barzilai is a chaired Professor of Medicine and Genetics and Director of the biggest Center in the world to study the Biology of Aging. He is the recipient of an NIH Merit Award aiming to extend the healthy life span in rodents by biological interventions. He also studies families of centenarians that have provided genetic/biological insights on the protection against aging. Several drugs are developed based, in part, on these paradigm-changing studies. He is a recipient of numerous prestigious awards, including the recipient of the 2010 Irving S. Wright Award of Distinction in Aging Research and is the 2018 recipient of the IPSEN Longevity award. He is leading the TAME (Targeting/Taming Aging with Metformin) multi central study to prove that concept that multi morbidities of aging can be delayed in humans and change the FDA indications to allow for next generation interventions. He is a founder of CohBar Inc. (now public company) and Medical Advisor for Life Biosciences. He is on the board of AFAR and CohBar He has been featured in major papers, TV program and documentaries (TEDx and TEDMED) and has been consulting or presented the promise for targeting aging at The Singapore Prime Minister Office, several International Banks, The Vatican, Pepsico, Milkin Institute, The Economist and Wired Magazine.
For Abstract click here
Dr. Pieter-Jan van Ooij, Consultant Diving Medicine and Scientific Researcher at the Diving Medical Center (DMC); Royal Netherlands Navy
Dr. van Ooij was trained in diving medicine by dr Rob van Hulst at the DMC. As parts of his training he followed the Advanced Diving Medical Officer course and the Submarine Medical Officer Course at DRDC Canada. In 2013 he obtained his Ph.D. from the University of Amsterdam for his study on pulmonary oxygen toxicity in professional divers. His main topic of interest is (hyperbaric) respiratory physiology, especially pulmonary oxygen toxicity. At the moment his main research is focused on the relation between pulmonary oxygen toxicity and changes in volatile organic compounds in exhaled breath.
Rahav Boussi-Gross (MA) is a Neuropsychologist and rehabilitation psychologist, with vast experience in the evaluation and treatment of patients with neurological and cognitive deficiencies. In the past decade, Rahav studies the effect of HBOT on cognitive and emotional state of different patients’ populations in the Sagol center for hyperbaric medicine and research. Rahav is also working on the implementation of new innovating technologies in the cognitive world and study their potential benefit to the hyperbaric treatment.
For Abstract click here
Dr. Ran Arieli
Retired Head of the Hyperbaric Physiology Research Unit at the Israel Naval Medical Institute
Dr. Arieli obtained his Ph.D. from Tel-Aviv University, completing a post-doctorate at Buffalo, The State University of New York. He lectured in respiration physiology at the Technion Faculty of Medicine in Haifa. His main topics of research are respiratory physiology, oxygen toxicity, and decompression physiology. Dr. Arieli has investigated the environmental factors which affect oxygen toxicity, proposing algorithms for the prediction of pulmonary and central nervous system oxygen toxicity. In the research of decompression physiology, Dr. Arieli has presented a new mechanism underlying bubble formation on decompression. Dr. Arieli has published 114 research papers, and continues to pursue his research at the Israel Naval Medical Institute in Haifa and the Western Galilee Medical Center in Nahariya, Israel.
Prof. Rony Paz attained a B.Sc. in Mathematics and a B.A. in Philosophy from the Hebrew University in Jerusalem in 1997. He then joined the Interdisciplinary-center for Neural-Computation (ICNC) and Obtained an M.Sc. and Ph.D. (summa cum laude, 2004) with Prof. Eilon Vaadia, working on Neural correlates of visuomotor learning. During these years he was also a project manager and senior R&D researcher at the Hightech industry, developing algorithms for customer profiling. Dr. Paz continued to be a post-doctoral associate at Rutgers university, working with Prof. Denis Pare and focusing on neural mechanisms that underlie emotional modulation of learning and memory. He started his own Lab at the Weizmann Institute in 2008, and was tenured and promoted to an associate professor in 2014. The Lab uses models derived from learning-theory to examine learning and memory formation under emotional situations. He strives to unveil the neural codes and brain circuits that allow normal learning and memory and how these interactions can result in maladaptive behavior that can result in PTSD, mood, and anxiety disorders. The lab studies humans (including patients) using cognitive psychology paradigms and imaging (fMRI) to unveil the underlying circuits, as well as animal-models in non-human-primates that use large-scale electrophysiology and stimulation methods. The main focus is the amygdala-prefrontal-cortex pathway.
For Abstract click here
Sandra Chapman is a Program Officer in the Warfighter Performance Department at the Office of Naval Research. Sandra has 7 years of experience working in science policy at various federal agencies in various different roles. Sandra became a Program Officer in January 2018 and manages the Undersea Medicine Program. Previously, Sandra provided support as a contractor at ONR for the Force Health Protection Program and for the Director of Research. In 2013, Sandra completed the American Association for the Advancement of Science (AAAS) Science and Technology Policy Fellowship with two tours, one in the Engineering Directorate Office of Evaluation and Assessment at the National Science Foundation (NSF) and the other at the Office of Cancer Nanotechnology Research at the National Institutes of Health (NIH). At the NSF, Sandra supervised the development of the right IT infrastructure for evaluation of the NSF’s SBIR program and created a longitudinal evaluation system for the Emerging Frontiers in Research and Innovation (EFRI) program. At the NIH, Sandra served as a project manager monitoring the progress of interdisciplinary nanotechnology-based research projects. Previously, she completed her graduate degree studying the life cycle of the human papillomavirus in its natural host, primary keratinocytes. Her work led to the discovery of a novel immortalization mechanism that has greatly expanded opportunities for research with primary cell cultures. Sandra is passionate about empowering female scientists and as a AAAS fellow Sandra co-founded an interest group focused on Women’s Issues in Science and Engineering (WISE).
Professor Shai Efrati, MD
Director of the Sagol Center for Hyperbaric Medicine and Research, Assaf-Harofeh Medical Center, Israel.
Director of Research & Development, Assaf-Harofeh Medical Center, Israel.
Professor at Sackler School of Medicine and the Sagol School of Neuroscience of Tel Aviv University.
Chairmen of the Israeli Society for Diving and Hyperbaric Medicine (ISDHM).
Dr. Shai Efrati is a professor at Sackler School of Medicine and the Sagol School of Neuroscience of Tel Aviv University and the director of the Sagol center for hyperbaric medicine and research at Assaf-Harofeh Medical Center in Israel. The center, under Prof. Efrati management, has become one of the largest hyperbaric center worldwide, currently treating more than 200 patients per day. Prof. Efrati is also the director of Research & Development of Assaf-Harofeh Medical center, affiliated to Tel-Aviv University. Taking the two passions/positions together Dr. Efrati has initiated a research program focusing on the biological effects of Hyperbaric Oxygen Therapy (HBOT) with special focus on brain neuroplasticity (regeneration of damage brain tissue). In the first clinical studies it was demonstrated that HBOT can induce neuroplasticity in post stroke and Traumatic Brain Injury even years after the acute Insult. The important clinical results gained from the research program have led to fruitful ongoing cooperation including multidiscipline team focusing on the regenerative effects of hyperbaric oxygen in various types of brain injuries, pain syndromes and age related functional decline.
1998 Ph.D. in the Department of Physiology, Hadassah Medical School, and the Department of Cell and Animal Biology, Institute for Life Sciences, the Hebrew University, Jerusalem. Doctoral dissertation: “The role of tissues, organelles, and membrane receptors in the cutaneous water evaporation cooling mechanism in the rock pigeon (Columba livia)”.
- 1997-2002 Research physiologist at the Israel Naval Medical Institute, Haifa.
- Main research topics: a) Can heat acclimation provide protection against CNS oxygen toxicity? b) The effect of hyperoxia on energetic efficiency in the trained rat. c) Can high frequency sound promote the development of gas bubbles?
- 2002-2004 Post-doctoral position in the laboratory of Prof. Saul Schaefer, MD, PhD at the Division of Cardiovascular Research, University of California at Davis, USA. Main topics of research: a) Gender differences in cardiac mitochondrial function in a rat model. b) The effect of acute tobacco smoke exposure on mitochondrial permeability transition in the rat heart.
- 2004 – Research physiologist at the Israel Naval Medical Institute (INMI), Haifa. Main topics of research: a) The role of mitochondria in CNS oxygen toxicity. b) Preconditioning with hyperbaric oxygen as a means of protection against CNS oxygen toxicity. c) The role of the blood-brain barrier in CNS oxygen toxicity. d) The effect of ultrasound on the development of decompression sickness. e) Yo-yo diving: the infiltration of gas bubbles from the venous to the arterial side. f) Myelin injury following decompression in rats.
- 2009-2016 Head of the Research Department at the Israel Naval Medical Institute.
- 2016 – Senior lecturer at Hadassah Medical School, Ein Kerem, Jerusalem.
- 1999-2006 Lecturer on the course “Physiology and medicine of man in the sea:” at The Interuniversity Institute for Marine Sciences in Eilat, The Hebrew University, Israel.
- 2004-2008 Lecturer on the course “Man in the sea: physiology and medicine”, at the Department of Maritime Civilizations, Haifa University, Israel.
- 2004-2013 Lecturer on the course “Physiology and medicine of man in the sea” for the Israel Navy’s Naval Officers’ Class, Haifa University, Israel.
- 2009-2013 Director of the course “Physiology and medicine of man in the sea” for the Israel Navy’s Naval Officers’ Class, Haifa University, Israel.
- 2010 – Lecturer on the course “Diving Physiology” for third year students at the “Tsameret” Faculty of Military Medicine, Hadassah Medical School, Ein Kerem, Hebrew University, Jerusalem.
Dr. Matsliah is Director of the Israel Naval Medical Institute. He is a graduate of the School of Medicine at Ben-Gurion University of the Negev (2001). He is a certified paediatrician (2013), and has practised diving and hyperbaric medicine throughout his military service at the Israel Naval Medical Institute.
He has conducted research into the effects of prolonged submersion on bone strength and metabolism in submariners, and an investigation into the effects of methylphenidate on the risk of CNS oxygen toxicity. He is in charge of the medical aspects of the submarine escape and rescue programme in the Israeli navy.
For Abstract click here
Dr Zemer Wang,
Certified Family Physician, dive and hyperbaric medicine.
Graduate of the Medical University of Vienna where he wrote his doctorial thesis titled: “Risk management in Hyperbaric Medicine”. Dr Wang worked as a hyperbaric chamber operator and tender during his medical studies. Dr Wang practices Family medicine in Eilat, Israel and heads the hyperbaric and diving medicine unit at the Yoseftal HP. To this day, he continues to be part of the Israeli Naval Medical Institute (INMI) as a reserve officer. Dr Wang participated in several humanitarian missions in Asia, Africa and south America. Dr Wang is an active member of the Israeli society for Hyperbaric medicine and Diving physiology and of the EUBS.